Not Tagged
Affini-T Therapeutics
[]
#affinittherapeutics presents preclinical data from its #oncogenic driver program targeting #kras at the #aacr23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.